The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...